1707 TAI Week ended 07 Aug 2026

Weekly Investor Report

Grape King Bio Ltd · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 89.20 TWD
-0.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -16.5% below the Trend Line and sits at 2.7% of its 52-week range. The latest completed week returned -0.1%, after a -2.6% four-week move. Near-term considerations: volume confirmation is below normal.

Setup score 21 out of 100
Latest Close 89.20 TWD 7 Aug 2026
1W Return -0.1% latest completed week
4W Return -2.6% short-term follow-through
12W Return -13.8% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.1% Latest completed week; four-week move -2.6%. Indicator stack 0/23 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.84% Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -16.5% below the Trend Line and sits at 2.7% of its 52-week range. The latest completed week returned -0.1%, after a -2.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.6% over four weeks, -13.8% over 12 weeks, and -27.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.1%
4W-2.6%
12W-13.8%
26W-23.5%
52W-27.5%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.46Latest activity-pressure read.
Pressure change-14.0%Four-week change in activity pressure.
Leadership-43.62Latest relative-leadership reading.
RS change7.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment-

No current sentiment snapshot is stored.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.6%Distance below the 52-week high.
13-week volatility2.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2617 weeks finished lower.
Best week+2.5%Week of 12 Jun.
Worst week-4.9%Week of 15 May.
Latest week-0.1%Week of 7 Aug.

Shape of recent returns

Strong gains0
Modest gains8
Flat weeks1
Modest losses14
Sharp losses3
Recent vol2.1%13-week weekly-return volatility.
Base vol1.8%52-week weekly-return volatility.
Up/down split18/30Count of positive and negative weeks in the 52-week window.
Average skew1.2% / -1.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape18/100

Trend, activity pressure, participation, and risk combine to a 18/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 40.84%

Next-week expectancy is negative with a 40.84% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

No sentiment snapshot is stored yet.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202689.20 TWD-0.1%106.8 TWD125.6 TWD-1.46-43.621.8MOff
31 Jul 202689.30 TWD-2.4%107.9 TWD126.0 TWD-1.49-43.102.5MOff
24 Jul 202691.50 TWD0.7%108.9 TWD126.4 TWD-1.48-43.432.3MOff
17 Jul 202690.90 TWD-0.8%109.8 TWD126.7 TWD-1.40-43.382.0MOff
10 Jul 202691.60 TWD-1.4%110.8 TWD127.0 TWD-1.28-47.132.1MOff
3 Jul 202692.90 TWD-2.6%111.9 TWD127.4 TWD-1.20-48.854.5MOff
26 Jun 202695.40 TWD-4.3%112.8 TWD127.7 TWD-1.22-45.772.8MOff
19 Jun 202699.70 TWD-0.5%113.6 TWD128.0 TWD-1.28-46.461.5MOff
12 Jun 2026100.2 TWD2.5%114.4 TWD128.3 TWD-1.34-44.291.5MOff
5 Jun 202697.76 TWD0.5%115.0 TWD128.6 TWD-1.37-47.551.9MOff
29 May 202697.27 TWD-1.9%115.6 TWD128.9 TWD-1.39-48.282.6MOff
22 May 202699.20 TWD-4.2%116.3 TWD129.2 TWD-1.38-45.062.0MOff
15 May 2026103.5 TWD-4.9%116.9 TWD129.5 TWD-1.29-41.991.5MOff
8 May 2026108.8 TWD0.4%117.5 TWD129.8 TWD-1.13-40.59714.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context